Fulgent Genetics Inc (FLGT)
20.74
+0.10
(+0.48%)
USD |
NASDAQ |
Apr 24, 16:00
20.76
+0.02
(+0.07%)
After-Hours: 20:00
Fulgent Genetics Total Liabilities (Quarterly): 102.04M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 102.04M |
| September 30, 2023 | 96.56M |
| June 30, 2023 | 91.25M |
| March 31, 2023 | 107.85M |
| December 31, 2022 | 116.18M |
| September 30, 2022 | 124.38M |
| June 30, 2022 | 150.93M |
| March 31, 2022 | 152.63M |
| December 31, 2021 | 112.84M |
| September 30, 2021 | 160.22M |
| June 30, 2021 | 129.13M |
| March 31, 2021 | 197.52M |
| December 31, 2020 | 131.07M |
| September 30, 2020 | 60.36M |
| June 30, 2020 | 8.872M |
| March 31, 2020 | 7.953M |
| Date | Value |
|---|---|
| December 31, 2019 | 5.979M |
| September 30, 2019 | 6.619M |
| June 30, 2019 | 5.294M |
| March 31, 2019 | 5.691M |
| December 31, 2018 | 2.752M |
| September 30, 2018 | 2.266M |
| June 30, 2018 | 2.987M |
| March 31, 2018 | 2.415M |
| December 31, 2017 | 3.006M |
| September 30, 2017 | 3.399M |
| June 30, 2017 | 3.072M |
| March 31, 2017 | 3.524M |
| December 31, 2016 | 3.561M |
| September 30, 2016 | 5.513M |
| June 30, 2016 | 5.075M |
| December 31, 2015 | 0.686M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.294M
Minimum
Jun 2019
197.52M
Maximum
Mar 2021
93.04M
Average
107.85M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| Delcath Systems Inc | 22.84M |
| Star Equity Holdings Inc | 10.20M |
| Exact Sciences Corp | 3.326B |
| CytoSorbents Corp | 29.99M |
| Progyny Inc | 203.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.235B |
| Shareholders Equity (Quarterly) | 1.136B |
| Debt to Equity Ratio | 0.0037 |
| Current Ratio | 6.955 |
| Net Debt Paydown Yield | 0.38% |